|
Tayutina T.V., Shlyk S.V.
Diagnostic value of systemic inflammation and endothelial dysfunction markers in the formation of chronic obstructive pulmonary disease clinical phenotypes
|
№7 / 2024
|
|
Iskenderov B.G., Lokhina T.V., Mozhzhukhina I.N., Berenshtein N.V., Zaitseva A.V.
Influence of vascular remodelling and reduced heart rate variability at indapamide efficacy in patients with arterial hypertension
|
№8 / 2023
|
|
Mashin V.V., Dolgova D.R., Belova L.A., Kotova E. Yu., Kruglova L.R., Statenina A.P., Kozin A.A., Israfilova R.R., Martynova D.K.
Diagnostic and prognostic significance of endothelial dysfunction biochemical markers in patients with discirculatory encephalopathy after COVID-19
|
№5 / 2023
|
|
Heylo T.S., Danilogorskaya Yu.A., Nazarenko G.B., Gladysheva E.G.
Dynamics of microcirculation indices in patients with chronic ischemic diseases of the central nervous and cardiovascular systems
|
№8 / 2021
|
|
Umetov M.A., Khakuasheva I.A., Akkaeva M.R., Tamazova M.A., Sanova A.Z., Khakulova D.M.
Influence of complex drug therapy on structural and functional properties of vessels and endothelial dysfunction in patients with arterial hypertension and ischemic heart disease
|
№8 / 2021
|
|
Chukanova E.I., Chukanova A.S., Bagmanyan S.D.
Chronic brain ischemia as an interdisciplinary problem
|
№5 / 2021
|
|
Heylo T.S., Danilogorskaya Yu.A., Nazarenko G.B., Martynov A.I.
Estimation of the influence of 6 week therapy by meldonium (Mildronate®) at bulbar capillaroscopy indexes in chronic ischemic heart and brain disease female patient
|
№3 / 2020
|
|
Solovieva E.Yu., Amelina I.P., Baranova O.A., Chekanov A.V.
Diagnostic markers of early phase of acute disorder of brain blood circulation in persons with КT-negative infarct data
|
№3 / 2020
|
|
Rogozina L.A., Lymareva L.V., Osadchuk A.M., Zolotovskaya A.I., Davydkin I.L.
Violation of endothelial function in patients with renal transplant
|
№2 / 2019
|
|
Statsenko M.E., Lopushkova Yu.E., Derevyanchenko M.V.
Study of arterial stiffness and C-reactive protein level in patients with chronic heart failure and chronic obstructive pulmonary disease
|
№1 / 2019
|
|
S.N. Tolpygina
Possibility of high-selective adrenoblockers use in combined therapy ofpatients with metabolic syndrome
|
№4 / 2018
|
Русский
